New approaches to the treatment of CNS disorders.
The meeting on Designing Drugs for Nervous System Disorders, held February 22, 2001, in a town that houses two major neuroscience research centers (GlaxoSmithKline and Merck) and that is close to several other companies working in this field, was ideally located to attract a good attendance by active neuroscientists. The selection of speakers presented a fascinating perspective of new approaches, early-stage programs and the treatment of CNS disorders.
Norman
P
P
Norman Consulting, Burnham, UK.